FDA approves Akebia's anemia drug

The U.S. Food and Drug Administration approved Akebia Therapeutics' (AKBA.O) drug, vadadustat, to treat anemia caused by chronic kidney disease (CKD) in dialysis patients, the drugmaker said on Wednesday.